AzTrials
AzTrials

Pre-Existing Type 2 Diabetes MellitusNCT05983120

Self-management and Quality of Life in Individuals With Type 2 Diabetes Mellitus

A study testing Education in people with Pre-Existing Type 2 Diabetes Mellitus, run by Afyonkarahisar Health Sciences University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study was conducted in order to study the effect of the training given according to social-cognitive learning theory (SCLT) upon diabetes self-management and quality of life among type 2 diabetes mellitus individuals. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Pre-Existing Type 2 Diabetes Mellitus
What is being tested?
Education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
19 Aug 2021to 3 Jan 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18 years and over
  • Being diagnosed with Type 2 diabetes mellitus,
  • Being on insulin therapy,
  • Being open to verbal communication,
  • Being literate
  • Not to have an obstacle to continue the implementation phase of the research (for example, pregnancy plan, changing province, etc.)
Show all 17Show fewer
  • Not having hearing-vision problems and diabetes-related serious neuropathy (amputation, etc.),
  • Patients who agreed to participate in the study.
  • Exclusion Criteria:The patient has a perception disorder and psychiatric disorder that prevents communication,
  • Being pregnant,
  • Individuals with serious complications such as retinopathy and neuropathy at the level of blindness were excluded from the study.
  • Research Termination Criteria
  • Not performing the specified applications properly during the study,
  • Unreachable in follow-ups,
  • Those who want to quit working,
  • Serious complications related to comorbid diseases and diabetes that occur during the working process,
  • The study was terminated with patients who were moved out of the province during the study.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Afyonkarahisar Health Sciences University

    Afyonkarahisar

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Education Provided According to Social Cognitive Learning Theory on Diabetes Self-management and Quality of Life in Individuals With Type 2 Diabetes Mellitus

The study was conducted in order to study the effect of the training given according to social-cognitive learning theory (SCLT) upon diabetes self-management and quality of life among type 2 diabetes mellitus individuals.

Read the detailed description

The study was done as a randomized-controlled experimental study at Internal Diseases Polyclinics of Afyonkarahisar Public Hospital between November 2021 and August 2022. The study was completed with 60 patients -experimental group (30 patients) and control group (30 patients)- who met inclusion criteria. The data were gathered using Information Request Form and Metabolic Variables Form, Diabetes Self-Management Scale (DSMS) for Type 2 Diabetic Patients, Multidimensional Scale of Perceived Social Support (MSPSS), Type 2 Diabetes Mellitus Self-Management Questionnaire (SMQ), WHOQOL-BREF (WHO- Quality of Life Scale- Short form). A theoretical and practical training based on SCLT was provided to the experimental group for the first five weeks -one module for each week- through power point presentations and afterwards, SMS reminders were sent every fifteen days for seven weeks and at the end of the twelfth week the training was completed. The control group received a standard training from diabetes nurse. The data were assessed using statistical methods.

Being tested
Education
Keywords
Type 2 Diabetes, Social Cognitive Learning, Diabetes Self-management, Quality of Life
Medical subject headings
Diabetes Mellitus, Type 2

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EducationOther

    Educate the patients who suffer from Type 2 Diabetes Mellitus

Study groups in NCT05983120
Study groupRoleWhat they receive
Training groupExperimentalIn the first five weeks, the experimental group was given training consisting of five modules, accompanied by power point presentations and applied social cognitive learning theory, then SMS reminders were sent every fortnight for seven weeks, and the study was completed at the end of the twelfth week. The control group received standard training from a diabetes nurse. Scale evaluations, metabolic and anthropometric measurements were made at the beginning and end of the study in the experimental and control groups. In addition, the scale evaluation was repeated in the fifth week for the experimental group. Data were evaluated using appropriate statistical methods.
Receives: Other: Education
Control GroupNo interventionThe control group received standard training from a diabetes nurse.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Determination of self-regulation capacity from the principles of SCLT.

    There is no specific score range.High scores on the scale indicate good self-management (SMQ), and low scores indicate poor self-management.

    In the intervention group, no significant change was observed in SMQ general score averages between PT2 and IT values compared to PT1. Similarly, no significant change was observed in PT2 values compared to PT1 regarding the control group score averages.

    Measured: twelve weeks

  2. Determination of self-judgment capacity, one of the principles of SCLT.

    DM was assessed with the Self-Efficacy Scale (DSMS). The lowest score that can be obtained from the scale is 20, and the highest score is 100. In the sample, the scale score average is calculated and individuals who are above the average are evaluated as high self-efficacy, and individuals below the average are evaluated as low self-efficacy.

    In the study, while the overall median score of DSMS in the intervention group showed a significant decrease in PT2 and IT values compared to PT1, no significant change was observed in the median DSMS scores of the control group.

    Measured: twelve weeks

  3. Determining the effect of SCLT-based education on Quality of Life

    Evaluated by WHOQOL - BREF (World Health Organization Quality of Life Scale - Short Form). It has four sub-dimensions: physical health such as pain, sleep, energy, psychological health such as positive emotions, self-confidence, body image, social relations such as social support, personal relations and environmental health such as economic status, transportation, safe environment and health conditions. A high score indicates a high quality of life.

    In the intervention group, no significant change was observed in the median values of physical health, psychological health, social relations, and environmental health, which are WHOQOL subscales, in PT2 and IT values compared to PT1. Compared to PT1 regarding the median score of the control group's social relations, a minimum significant increase was observed in PT2 values, but no significant change was found in other subscales

    Measured: twelve weeks

Secondary outcomes (4)
  1. Determination of blood HbA1c value.

    HbA1c (glycosylated hemoglobin). Indicates the average blood glucose value over the last 2 to 3 months. The HbA1c reference range should be 5.7-6.4%. HbA1c level ≥6.5% or ≤5.6 poor glycemic control.

    In the intervention group, a significant decrease in the mean values of HbA1c, metabolic variables was observed compared to PT1 (9,53 ± 2,34) and PT2 ( 8,54 ± 1,77).

    Measured: twelve weeks

  2. Determination of Fasting Blood Glucose (FBS) value.

    It is the glucose value (plasma glucose) measured from a blood sample taken after eight or twelve hours of fasting. The normal reference range is min 80 mg/dl - max 130 mg/dl. FBS level ≥130 mg/dl or ≤80 mg/dl poor glycemic control.

    In the intervention group, a significant decrease in the mean values of FBS metabolic variables was observed compared to PT1 (224,77 ± 101,57) and PT2 (168,53 ± 65,27).

    Measured: twelve weeks

  3. Determination of blood Postprandial Blood Glucose (PBS) value.

    PBS is the plasma glucose value measured two hours after the start of food intake after an eight-hour fast. The reference range is 140-199 mg/dl. TKS ≥200 mg/dl or ≤139 mg/dl a weak glycemic control.

    Compared to PT1 (289,13 ± 114,06), the decrease in PBS mean values in PT2 (264,93 ± 91,55) were not significant change was found.

    Measured: twelve weeks

  4. Determination of blood fasting lipid profile (total cholesterol, HDL-cholesterol, LDL-cholesterol, triglyceride) values.

    A blood sample taken after eight or twelve hours of fasting is used to determine the fasting lipid profile (total cholesterol, HDL-cholesterol, LDL-cholesterol, triglyceride) values. Fasting lipid profile reference range is (Total cholesterol 20 - 200 mg/dl, High Density Lipoprotein (HDL) reference range is 35 - 65 mg/dl, Low Density Lipoprotein (LDL) reference range is 60 - 130 mg/dl, Triglyceride reference range is 20 - 203 mg/dl). Values less or higher than the specified values are considered as negative cholesterol levels.

    In the intervention group, a significant decrease in the mean values of total cholesterol was observed compared to PT1(192,87 ± 35,87) and PT2 (183,37 ± 36,26) measurements. Compared to PT1, although the decrease in LDL mean values and triglyceride median values in PT2 measurements were not significant, no significant change was found in the HDL value.

    Measured: twelve weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Aug 2023
  2. Study start19 Aug 2021
  3. Primary completion20 Aug 2022
  4. Study completion3 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05983120
Sponsor's protocol ID
Afyonkarahisar HSU
Status last verified
Sep 2024
First submitted
7 Jan 2023
Last updated
1 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Education in people with Pre-Existing Type 2 Diabetes Mellitus, run by Afyonkarahisar Health Sciences University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 17 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Determination of self-regulation capacity from the principles of SCLT. (time frame: twelve weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in